Prevalence and Determinants of Anemia and Iron Deficiency Anemia Among Patients With Diabetes Mellitus in Cameroon: An Analytical Cross-Sectional Study

喀麦隆糖尿病患者贫血和缺铁性贫血的患病率及决定因素:一项分析性横断面研究

阅读:2

Abstract

BACKGROUND AND AIMS: Anemia is a significant complication that worsens disease outcomes. They can be multifactorial, including micronutrient deficiencies and iron deficiencies. This study aimed to determine the prevalence and associated factors of anemia and iron deficiency anemia (IDA) among diabetic patients in Cameroon. METHODS: An analytical cross-sectional study was conducted over 4 months from August to November 2024. A total of 210 diabetic patients, attending the diabetology unit of the regional hospital in the West Region of Cameroon, were studied, with their age range between 20 and 70 years. Blood samples were taken for biological tests, including blood count, glycemia, glycated hemoglobin, ferritin, and serum, following standard assay protocols. The results obtained were analyzed using the R statistical tool version 4.1.1. RESULTS: The sex ratio was 0.89, and the mean age was 48.32 ± 18.19 years. A total of 48.6% of patients were overweight. The frequency of anemia was observed in 72 females (53%) and 63 males (46.7%), with a total frequency of 64.3%. A total of 8.57% were found to have IDA. Anemias were characterized by microcytosis [11.1% in anemic patients versus none in non-anemic patients (p < 0.001)], hypochromia [88.9% in anemic patients versus 72% in non-anemic patients (p < 0.001)], and greater regeneration in anemic patients versus non-anemic patients (p < 0.001). Macroplateletosis and high Hb1AC were identified as predictive factors for IDA in diabetes with (OR = 2.83, 95% CI = [1.17; 6.80]; p = 0.021) and OR = 2.33, 95% CI = [0.14; 3.19], p = 0.044, respectively. CONCLUSION: This study reports a significant frequency of anemia and IDA in diabetic patients; the latter is associated with worsening clinical manifestations. Routine screening for anemia and iron deficiency is recommended in diabetic patients to enable timely intervention and reduce related complications.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。